DORIPENEM vs DOSTARLIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DORIPENEM vs DOSTARLIMAB: Safety Overview
| Metric | DORIPENEM | DOSTARLIMAB |
|---|---|---|
| Total FAERS Reports | 239 | 893 |
| Deaths Reported | 78 | 130 |
| Death Rate | 32.6% | 14.6% |
| Hospitalizations | 91 | 441 |
| Average Patient Age | 56.2 yrs | 65.8 yrs |
| % Female Patients | 35.4% | 91.6% |
| FDA Approval Date | Oct 12, 2007 | N/A |
| Manufacturer | N/A | GlaxoSmithKline LLC |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Discontinued | N/A |